11 patients were diagnosed as DLBCL immunohistochemically, including 4 patients confirmed as double expression (BCL-2 and MYC) DLBCL and one patient (P10) confirmed as triple hit lymphoma (THL) by further analysis of fluorescence in situ hybridization (FISH). The gene discussed is MYC; the disease is lymphoma.